WST West Pharmaceutical Services, Inc. Common Stock
NYSE · Life Sciences Tools & Services · Wyświetl na SEC EDGAR ↗ 10-K/10-Q Lip 23, 2026
$392,15
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$223,8352tyg. minimum
$397,1652tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$27.61B
P/E (TTM)
50.2
EPS (TTM)
$7.81
Przychody (TTM)
$3.33B
Twoje odznaki
Zakres 52 tyg.
$224–$397
Ocena Analityków
BUY
Cena Docelowa
$413
P/E
50.2
ROE
19.1%
Marża Zysku Netto
17.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
WST Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$392.15
Kapitalizacja Rynkowa (MRQ)
$27.61B
P/E (TTM)
50.2
EPS (TTM)
$7.81
Przychody (TTM)
$3.33B
Stopa dywidendy
0.22%
ROE (TTM)
19.1%
D/E Dług/Kapitał (MRQ)
0.1
Zakres 52 tyg.
$224–$397
WST Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 27 września 2013 | 2-for-1 | Naprzód |
| 29 września 2004 | 2-for-1 | Naprzód |
| 2 czerwca 1987 | 2-for-1 | Naprzód |
| 6 maja 1982 | 2-for-1 | Naprzód |
O West Pharmaceutical Services, Inc. Common Stock Przegląd firmy z Wikipedii
sektorHealthcare
branżaLife Sciences Tools & Services
pracownicy10 800
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$3.07B2016-12-31 → 2025-12-31
EPS$6.792016-12-31 → 2025-12-31
Wolny przepływ pieniężny$469M2016-12-31 → 2025-12-31
Marża netto17.0%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | WST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 50.2średnia z 5 lat ≈43.7 | ≈43.7 | 31.1 | Zawyżona wycena | |
| P/S (TTM) | 8.3średnia z 5 lat ≈8.3 | ≈8.3 | 5.3 | Zawyżona wycena | |
| P/B (MRQ) | 9.2średnia z 5 lat ≈9.1 | ≈9.1 | 6.9 | Droższy | |
| EV / EBITDA | 36.6średnia z 5 lat ≈29.5 | ≈29.5 | 22.9 | Zawyżona wycena | |
| Cena / FCF (TTM) | 63.2średnia z 5 lat ≈67.1 | ≈67.1 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 41.7średnia z 5 lat ≈35.9 | ≈35.9 | 24.3 | Wartość godziwa | |
| EV / Revenue (EV / Przychody) | 9.0średnia z 5 lat ≈8.2 | ≈8.2 | · | · | |
| EV / FCF | 59.0średnia z 5 lat ≈65.7 | ≈65.7 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 9.3średnia z 5 lat ≈9.5 | ≈9.5 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈6.1 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | WST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 36.8%średnia z 5 lat ≈37.9% | ≈37.9% | 50.5% | Słaby | |
| Marża Operacyjna (TTM) | 20.5%średnia z 5 lat ≈22.7% | ≈22.7% | 17.4% | Najwyższa półka | |
| Marża EBITDA (TTM) | 25.9%średnia z 5 lat ≈27.5% | ≈27.5% | 18.6% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | 20.8%średnia z 5 lat ≈22.7% | ≈22.7% | 18.4% | Zgodnie z | |
| Marża Zysku Netto (TTM) | 17.0%średnia z 5 lat ≈19.4% | ≈19.4% | 15.8% | Zgodnie z | |
| ROA (TTM) | 14.1%średnia z 5 lat ≈16.0% | ≈16.0% | 11.5% | Zgodnie z | |
| ROE (TTM) | 19.1%średnia z 5 lat ≈21.4% | ≈21.4% | 18.4% | Zgodnie z | |
| ROIC | 13.8%średnia z 5 lat ≈18.8% | ≈18.8% | 13.8% | Zgodnie z |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | WST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.1średnia z 5 lat ≈0.1 | ≈0.1 | 0.2 | Niski dług | |
| Wskaźnik bieżący (MRQ) | 2.8średnia z 5 lat ≈3.1 | ≈3.1 | 1.6 | Silna płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 2.1średnia z 5 lat ≈2.2 | ≈2.2 | 0.8 | Silna płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.1średnia z 5 lat ≈0.1 | ≈0.1 | 0.4 | Niski dług |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | WST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 6.2%średnia z 5 lat ≈8.1% | ≈8.1% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 2.1%średnia z 5 lat ≈4.7% | ≈4.7% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 7.4% | · | · | · | |
| EPS YoY | 1.5%średnia z 5 lat ≈13.4% | ≈13.4% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 0.20%średnia z 5 lat ≈12.8% | ≈12.8% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | -4.2%średnia z 5 lat ≈2.5% | ≈2.5% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 8.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -5.5%średnia z 5 lat ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 7.4% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | WST | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.8średnia z 5 lat ≈0.8 | ≈0.8 | 0.6 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 4.8średnia z 5 lat ≈4.6 | ≈4.6 | 3.0 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 5.5średnia z 5 lat ≈5.8 | ≈5.8 | 5.3 | Zgodnie z | |
| Revenue / Employee (Przychody / pracownika) | ≈$284.6K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy0.22%
Wskaźnik Wypłaty Dywidendy12.4%
Zannualizowane wypłaty≈$0.88
CAGR dywidendy 5-letni≈5.6%
Seria wzrostów≈33
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Lip 29, 2026 | $0,22 | USD | ≈0.26% |
| Kwi 29, 2026 | $0,22 | USD | ≈0.29% |
| Sty 28, 2026 | $0,22 | USD | ≈0.36% |
| Lis 12, 2025 | $0,22 | USD | ≈0.31% |
| Lip 30, 2025 | $0,21 | USD | ≈0.34% |
| Kwi 30, 2025 | $0,21 | USD | ≈0.39% |
| Lut 7, 2025 | $0,21 | USD | ≈0.26% |
| Lis 13, 2024 | $0,21 | USD | ≈0.24% |
| Lip 31, 2024 | $0,20 | USD | ≈0.26% |
| Kwi 23, 2024 | $0,20 | USD | ≈0.20% |
| Sty 30, 2024 | $0,20 | USD | ≈0.21% |
| Lis 7, 2023 | $0,20 | USD | ≈0.23% |
| Lip 25, 2023 | $0,19 | USD | ≈0.20% |
| Kwi 25, 2023 | $0,19 | USD | ≈0.21% |
| Sty 24, 2023 | $0,19 | USD | ≈0.29% |
| Lis 8, 2022 | $0,19 | USD | ≈0.33% |
| Lip 19, 2022 | $0,18 | USD | ≈0.24% |
| Kwi 19, 2022 | $0,18 | USD | ≈0.19% |
| Sty 18, 2022 | $0,18 | USD | ≈0.19% |
| Lis 9, 2021 | $0,18 | USD | ≈0.17% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
16.9%
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 22, 2026 | $2.37 | $2.10 | 12.8% |
| 31 marca 2026 | $2.13 | $1.69 | 25.8% | |
| 31 grudnia 2025 | $2.04 | $1.85 | 10.2% | |
| 30 września 2025 | $1.96 | $1.70 | 15.4% | |
| 30 czerwca 2025 | $1.84 | $1.52 | 20.7% | |
| 31 marca 2025 | $1.45 | $1.25 | 16.4% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.07B | $2.89B | $2.95B | $2.89B | $2.83B | $2.15B | $1.84B | $1.72B | $1.60B | $1.51B | $1.40B | $1.42B | |
| Cost of Revenue | $1.97B | $1.89B | $1.82B | $1.75B | $1.66B | $1.38B | $1.23B | $1.17B | $1.09B | $1.01B | $944M | $974M | |
| Gross Profit | $1.10B | $998M | $1.13B | $1.14B | $1.18B | $768M | $606M | $545M | $513M | $501M | $456M | $448M | |
| R&D Expense | $74M | $69M | $68M | $58M | $53M | $47M | $39M | $40M | $39M | $37M | $34M | $37M | |
| SG&A Expense | $394M | $338M | $353M | $317M | $363M | $302M | $273M | $263M | $246M | $240M | $233M | $229M | |
| Operating Income | $585M | $570M | $676M | $734M | $752M | $407M | $297M | $240M | $226M | $195M | $129M | $182M | |
| Interest Expense | · | · | $9M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $14M | $16M | |
| Other Non-op | $-1M | $-1M | $3M | $-51M | $4M | $1M | $-100.0K | $7M | $3M | $2M | · | · | |
| Pretax Income | $601M | $586M | $698M | $680M | $749M | $401M | $292M | $241M | $222M | $190M | $116M | $169M | |
| Income Tax | $122M | $108M | $122M | $115M | $107M | $72M | $59M | $41M | $81M | $54M | $26M | $47M | |
| Net Income | $494M | $493M | $593M | $586M | $662M | $346M | $242M | $207M | $151M | $144M | $96M | $127M | |
| EPS (Basic) | $6.83 | $6.75 | $7.98 | $7.87 | $8.89 | $4.68 | $3.27 | $2.80 | $2.04 | $1.96 | $1.33 | $1.79 | |
| EPS (Diluted) | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 | $4.57 | $3.21 | $2.74 | $1.99 | $1.91 | $1.30 | $1.75 | |
| Shares (Basic) | 72,300,000 | 73,000,000 | 74,300,000 | 74,400,000 | 74,400,000 | 73,900,000 | 74,000,000 | 73,900,000 | 73,900,000 | 73,300,000 | 72,000,000 | 70,900,000 | |
| Shares (Diluted) | 72,700,000 | 73,700,000 | 75,300,000 | 75,800,000 | 76,300,000 | 75,800,000 | 75,400,000 | 75,400,000 | 75,800,000 | 75,000,000 | 73,800,000 | 72,800,000 | |
| EBITDA | $756M | $725M | $813M | $855M | $875M | $516M | $400M | $345M | $326M | $288M | $218M | $272M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $791M | $485M | $854M | $894M | $763M | $616M | $439M | $337M | $236M | $203M | $275M | $255M | |
| Receivables | $574M | $552M | $512M | $507M | $489M | $385M | $319M | $288M | $253M | $200M | $181M | $179M | |
| Inventory | $444M | $377M | $435M | $415M | $378M | $321M | $236M | $214M | $215M | $199M | $181M | $182M | |
| Other Current Assets | $169M | $124M | $136M | $103M | $112M | $52M | $65M | $54M | $39M | $39M | $37M | $36M | |
| Current Assets | $1.98B | $1.54B | $1.94B | $1.92B | $1.74B | $1.37B | $1.06B | $894M | $744M | $642M | $674M | $659M | |
| PP&E (Net) | $1.73B | $1.58B | $1.41B | $1.16B | $1.06B | $943M | $839M | $822M | $855M | $778M | $721M | $706M | |
| PP&E (Gross) | $3.22B | $2.99B | $2.74B | $2.39B | $2.21B | $2.04B | $1.82B | $1.75B | $1.75B | $1.55B | $1.44B | $1.39B | |
| Accum. Depreciation | $1.50B | $1.40B | $1.32B | $1.23B | $1.16B | $1.09B | $981M | $931M | $891M | $776M | $719M | $685M | |
| Goodwill | $110M | $106M | $108M | $107M | $110M | $111M | $108M | $106M | $108M | $103M | $105M | $109M | |
| Intangibles | $8M | $11M | $15M | $18M | $23M | $30M | $30M | $20M | $22M | $23M | $38M | $42M | |
| Other Non-current Assets | $80M | $74M | $21M | $38M | $39M | $23M | $25M | $20M | $23M | $21M | $26M | $28M | |
| Total Assets | $4.27B | $3.64B | $3.83B | $3.62B | $3.31B | $2.79B | $2.34B | $1.98B | $1.86B | $1.72B | $1.70B | $1.67B | |
| Accounts Payable | $254M | $239M | $242M | $215M | $232M | $213M | $157M | $130M | $138M | $122M | $120M | $103M | |
| Accrued Liabilities | $39M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $655M | $550M | $672M | $519M | $594M | $503M | $342M | $284M | $280M | $241M | $314M | $252M | |
| Capital Leases | $96M | $82M | $84M | $93M | $63M | $60M | $62M | $0 | · | · | · | · | |
| Deferred Tax | $23M | $20M | $13M | $14M | $5M | $10M | $16M | $13M | $10M | $9M | $12M | $16M | |
| Other Non-current Liabilities | $75M | $62M | $58M | $52M | $38M | $32M | $23M | $34M | $43M | $47M | $54M | $53M | |
| Total Liabilities | $1.09B | $961M | $948M | $932M | $978M | $939M | $768M | $583M | $583M | $599M | $671M | $713M | |
| Long-term Debt | $203M | $203M | $207M | $209M | $253M | $255M | $257M | $196M | $197M | $229M | $298M | $336M | |
| Total Debt | $203M | $203M | $207M | $209M | $253M | $255M | $255M | $196M | $197M | $226M | $229M | $310M | |
| Common Stock | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $18M | $18M | $18M | |
| Paid-in Capital | $0 | $22M | $120M | $232M | $249M | $267M | $273M | $282M | $309M | $260M | $208M | $160M | |
| Retained Earnings | $4.37B | $3.96B | $3.52B | $2.99B | $2.46B | $1.85B | $1.55B | $1.35B | $1.18B | $1.07B | $965M | $902M | |
| Treasury Stock | $1.11B | $1.06B | $638M | $371M | $230M | $168M | $118M | $104M | $109M | $46M | $4M | $4M | |
| AOCI | $-106M | $-258M | $-144M | $-183M | $-160M | $-111M | $-150M | $-154M | $-117M | $-187M | $-163M | $-119M | |
| Stockholders' Equity | $3.18B | $2.68B | $2.88B | $2.68B | $2.34B | $1.85B | $1.57B | $1.40B | $1.28B | $1.12B | $1.02B | $957M | |
| Liabilities + Equity | $4.27B | $3.64B | $3.83B | $3.62B | $3.31B | $2.79B | $2.34B | $1.98B | $1.86B | $1.72B | $1.70B | $1.67B | |
| Shares Outstanding | 72,000,000 | 72,300,000 | 73,500,000 | 74,100,000 | 74,200,000 | 74,000,000 | 74,100,000 | 74,100,000 | 73,900,000 | 73,100,000 | 72,300,000 | 71,300,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $171M | $155M | $137M | $121M | $122M | $109M | $103M | $104M | $97M | $91M | $90M | $90M | |
| Stock-based Comp | $24M | $19M | $23M | $24M | $38M | $34M | $24M | $15M | $16M | $20M | $30M | $19M | |
| Deferred Tax | $-14M | $-4M | $38M | $-31M | $-43M | $-6M | $15M | $900.0K | $42M | $22M | $-9M | $7M | |
| Amort. of Intangibles | $3M | $4M | $4M | $4M | $5M | $4M | $3M | $3M | $2M | $3M | $4M | $5M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $26M | · | · | |
| Other Non-cash | $80M | $-10M | $-15M | $25M | $-195M | $-11M | $-18M | $-39M | $-42M | $-56M | $6M | $-60M | |
| Operating Cash Flow | $755M | $653M | $776M | $724M | $584M | $472M | $367M | $289M | $263M | $219M | $212M | $183M | |
| CapEx | $286M | $377M | $362M | $285M | $253M | $174M | $126M | $105M | $131M | $170M | $132M | $112M | |
| Investing Cash Flow | $-286M | $-379M | $-369M | $-288M | $-253M | $-180M | $-228M | $-101M | $-134M | $-176M | $-130M | $-104M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Debt Issued | $0 | $-169M | · | $-1M | $0 | $0 | $-100.0K | · | · | · | $0 | $0 | |
| Stock Repurchased | $134M | $561M | $438M | $203M | $137M | $116M | $83M | $71M | $74M | $52M | $0 | $0 | |
| Net Stock Activity | $-134M | $-561M | $-438M | $-203M | $-137M | $-116M | $-83M | $-71M | $-74M | $-52M | · | · | |
| Dividends Paid | $61M | $59M | $57M | $54M | $51M | $48M | $45M | $42M | $39M | $36M | $32M | $29M | |
| Financing Cash Flow | $-185M | $-623M | $-460M | $-294M | $-168M | $-137M | $-37M | $-81M | $-109M | $-114M | $-42M | $-31M | |
| Net Change in Cash | $307M | $-369M | $-40M | $132M | $147M | $176M | $102M | $102M | $33M | $-72M | $19M | $25M | |
| Taxes Paid | $125M | $71M | $91M | $110M | $172M | $48M | $48M | $42M | $31M | $48M | $33M | $37M | |
| Free Cash Flow | $469M | $276M | $414M | $439M | $331M | $298M | $241M | $184M | $132M | $49M | $81M | $71M | |
| Levered FCF | · | · | $407M | $433M | $324M | $291M | $234M | $177M | $128M | $43M | $70M | $59M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.9% | 34.5% | 38.3% | 39.4% | 41.5% | 35.8% | 32.9% | 31.8% | 32.1% | 33.2% | 32.6% | 31.5% | |
| Operating Margin | 19.0% | 19.7% | 22.9% | 25.4% | 26.6% | 18.9% | 16.1% | 14.0% | 14.3% | 13.0% | 9.2% | 12.8% | |
| Net Margin | 16.1% | 17.0% | 20.1% | 20.3% | 23.4% | 16.1% | 13.1% | 12.0% | 9.4% | 9.5% | 6.8% | 8.9% | |
| Pretax Margin | 19.6% | 20.2% | 23.7% | 23.5% | 26.5% | 18.7% | 15.9% | 14.0% | 13.9% | 12.6% | 8.3% | 11.9% | |
| EBITDA Margin | 24.6% | 25.1% | 27.6% | 29.6% | 30.9% | 24.0% | 21.7% | 20.1% | 20.4% | 19.1% | 15.6% | 19.1% | |
| ROA | 12.5% | 13.2% | 15.9% | 16.9% | 21.7% | 13.5% | 11.2% | 10.8% | 8.4% | 8.4% | 5.7% | 7.6% | |
| ROE | 16.2% | 18.1% | 20.6% | 22.7% | 29.2% | 19.4% | 15.8% | 15.1% | 12.6% | 13.4% | 9.7% | 13.6% | |
| ROIC | 13.8% | 16.1% | 18.1% | 21.1% | 24.9% | 15.8% | 12.9% | 12.5% | 9.9% | 10.4% | 7.9% | 10.4% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 2.8 | 2.9 | 3.7 | 2.9 | 2.7 | 3.1 | 3.2 | 2.7 | 2.7 | 2.1 | 2.6 | |
| Quick Ratio | 2.1 | 1.9 | 2.0 | 2.7 | 2.1 | 2.0 | 2.2 | 2.2 | 1.7 | 1.7 | 1.5 | 1.7 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | |
| LT Debt / Equity | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | |
| Interest Coverage | · | · | 75.1 | 92.9 | 91.7 | 49.6 | 34.9 | 28.6 | 29.3 | 24.3 | 9.1 | 11.0 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.8 | 0.9 | |
| Inventory Turnover | 4.8 | 4.7 | 4.3 | 4.4 | 4.7 | 5.0 | 5.5 | 5.7 | 5.2 | 5.3 | 5.2 | 5.4 | |
| Receivables Turnover | 5.5 | 5.4 | 5.8 | 5.8 | 6.5 | 6.1 | 6.1 | 6.1 | 7.0 | 7.9 | 7.8 | 7.8 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $44.11 | $37.10 | $39.20 | $36.23 | $31.47 | $25.06 | $21.23 | $18.84 | $17.32 | $15.29 | $14.16 | $13.42 | |
| Revenue / Share | $42.28 | $39.26 | $39.17 | $38.09 | $37.11 | $28.32 | $24.40 | $22.78 | $21.10 | $20.12 | $18.97 | $19.52 | |
| Cash Flow / Share | $10.38 | $8.87 | $10.31 | $9.55 | $7.65 | $6.23 | $4.87 | $3.83 | $3.47 | $2.93 | $2.88 | $2.51 | |
| Cash / Share | $10.99 | $6.70 | $11.62 | $12.07 | $10.28 | $8.32 | $5.93 | $4.55 | $3.19 | $2.78 | $3.80 | $3.58 | |
| Dividend / Share | $0.86 | $0.82 | $0.78 | $0.74 | $0.70 | $0.66 | $0.62 | $0.58 | $0.54 | $0.50 | $0.46 | $0.41 | |
| EPS (TTM) | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 | $4.57 | $3.21 | $2.74 | $1.99 | $1.91 | $1.30 | $1.75 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.2% | -1.9% | 2.2% | 1.9% | 31.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.1% | 0.72% | 11.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1.5% | -15.1% | 1.9% | -10.8% | 89.7% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -4.2% | -8.3% | 19.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 8.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 0.20% | -17.0% | 1.3% | -11.5% | 91.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | -9.4% | 19.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.07B | $2.89B | $2.95B | $2.89B | $2.83B | $2.15B | $1.84B | $1.72B | $1.60B | $1.51B | $1.40B | $1.42B | |
| Net Income TTM | $494M | $493M | $593M | $586M | $662M | $346M | $242M | $207M | $151M | $144M | $96M | $127M | |
| Market Cap | $19.81B | $23.68B | $25.88B | $17.44B | $34.80B | $20.96B | $11.14B | $7.26B | $7.29B | $6.20B | $4.35B | $3.80B | |
| Enterprise Value | $19.22B | $23.40B | $25.23B | $16.75B | $34.29B | $20.60B | $10.96B | $7.12B | $7.25B | $6.22B | $4.31B | $3.85B | |
| P/E | 40.5 | 49.0 | 44.7 | 30.4 | 54.1 | 62.0 | 46.8 | 35.8 | 49.6 | 44.4 | 46.3 | 30.4 | |
| P/S | 6.4 | 8.2 | 8.8 | 6.0 | 12.3 | 9.8 | 6.1 | 4.2 | 4.6 | 4.1 | 3.1 | 2.7 | |
| P/B | 6.2 | 8.8 | 9.0 | 6.5 | 14.9 | 11.3 | 7.1 | 5.2 | 5.7 | 5.5 | 4.3 | 4.0 | |
| P / Tangible Book | 6.5 | 9.2 | 9.4 | 6.8 | 15.8 | 12.2 | · | · | · | · | · | · | |
| P / Cash Flow | 26.2 | 36.2 | 33.3 | 24.1 | 59.6 | 44.4 | 30.3 | 25.2 | 27.7 | 28.3 | 20.5 | 20.8 | |
| P / FCF | 42.2 | 85.7 | 62.4 | 39.7 | 105.3 | 70.3 | 46.3 | 39.5 | 55.0 | 126.0 | 53.9 | 53.5 | |
| EV / EBITDA | 25.4 | 32.3 | 31.0 | 19.6 | 39.2 | 39.9 | 27.4 | 20.7 | 22.3 | 21.6 | 19.7 | 14.2 | |
| EV / FCF | 41.0 | 84.7 | 60.9 | 38.1 | 103.7 | 69.1 | 45.5 | 38.7 | 54.7 | 126.5 | 53.3 | 54.2 | |
| EV / Revenue | 6.3 | 8.1 | 8.6 | 5.8 | 12.1 | 9.6 | 6.0 | 4.1 | 4.5 | 4.1 | 3.1 | 2.7 | |
| Dividend Yield | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.40% | 0.58% | 0.54% | 0.58% | 0.74% | 0.77% | |
| Earnings Yield | 2.5% | 2.0% | 2.2% | 3.3% | 1.8% | 1.6% | 2.1% | 2.8% | 2.0% | 2.2% | 2.2% | 3.3% | |
| Payout Ratio | 12.4% | 12.0% | 9.6% | 9.2% | 7.7% | 13.9% | 18.7% | 20.3% | 25.9% | 24.9% | 33.9% | 22.9% | |
| Annual Payout | $61M | $59M | $57M | $54M | $51M | $48M | $45M | $42M | $39M | $36M | $32M | $29M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $872M | $845M | $805M | $805M | $766M | $698M | $749M | $747M | $702M | $695M | $732M | $747M | $754M | $717M | $709M | $687M | |
| Cost of Revenue | $543M | $548M | $501M | $510M | $493M | $466M | $475M | $482M | $472M | $465M | $454M | $459M | $462M | $445M | $447M | $419M | |
| Gross Profit | $329M | $296M | $304M | $294M | $274M | $232M | $274M | $265M | $230M | $230M | $278M | $288M | $291M | $271M | $262M | $268M | |
| R&D Expense | $20M | $16M | $22M | $17M | $19M | $16M | $18M | $16M | $18M | $18M | $18M | $16M | $16M | $17M | $16M | $14M | |
| SG&A Expense | $118M | $100M | $107M | $103M | $96M | $88M | $85M | $84M | $83M | $87M | $90M | $89M | $88M | $86M | $86M | $66M | |
| Operating Income | $179M | $177M | $157M | $168M | $154M | $107M | $160M | $161M | $126M | $123M | $161M | $177M | $182M | $155M | $130M | $186M | |
| Interest Expense | · | · | · | · | · | · | · | $700.0K | · | $2M | · | $3M | $3M | $2M | · | $2M | |
| Other Non-op | $-200.0K | $-200.0K | $-400.0K | $-200.0K | $-200.0K | $-200.0K | $-300.0K | $-700.0K | $0 | $0 | $-4M | $4M | $100.0K | $3M | $-300.0K | $-49M | |
| Pretax Income | $180M | $180M | $162M | $172M | $157M | $110M | $165M | $164M | $129M | $127M | $168M | $187M | $185M | $158M | $129M | $136M | |
| Income Tax | $32M | $45M | $33M | $34M | $30M | $24M | $37M | $32M | $22M | $16M | $34M | $29M | $35M | $24M | $29M | $20M | |
| Net Income | $154M | $139M | $132M | $140M | $132M | $90M | $130M | $136M | $111M | $115M | $137M | $161M | $155M | $140M | $103M | $121M | |
| EPS (Basic) | $2.17 | $1.93 | $1.83 | $1.94 | $1.82 | $1.24 | $1.79 | $1.87 | $1.52 | $1.57 | $1.85 | $2.17 | $2.08 | $1.88 | $1.38 | $1.62 | |
| EPS (Diluted) | $2.15 | $1.92 | $1.82 | $1.92 | $1.82 | $1.23 | $1.78 | $1.85 | $1.51 | $1.55 | $1.83 | $2.14 | $2.06 | $1.85 | $1.37 | $1.59 | |
| Shares (Basic) | 70,800,000 | 72,000,000 | · | 72,200,000 | 72,200,000 | 72,500,000 | · | 72,800,000 | 73,000,000 | 73,500,000 | · | 74,300,000 | 74,300,000 | 74,500,000 | · | 74,400,000 | |
| Shares (Diluted) | 71,300,000 | 72,400,000 | · | 72,600,000 | 72,500,000 | 73,000,000 | · | 73,400,000 | 73,700,000 | 74,300,000 | · | 75,300,000 | 75,400,000 | 75,700,000 | · | 75,700,000 | |
| EBITDA | $225M | $222M | · | $211M | $195M | $147M | · | $161M | $126M | $123M | · | $177M | $182M | $155M | · | $186M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $436M | $521M | $791M | $628M | $510M | $404M | $485M | $491M | $446M | $602M | · | $899M | $796M | $886M | · | $729M | |
| Receivables | $712M | $686M | $574M | $625M | $582M | $544M | $552M | $524M | $479M | $524M | · | $519M | $534M | $513M | · | $485M | |
| Inventory | $447M | $453M | $444M | $438M | $421M | $389M | $377M | $401M | $419M | $430M | · | $432M | $449M | $447M | · | $413M | |
| Other Current Assets | $212M | $167M | $169M | $132M | $168M | $121M | $124M | $134M | $138M | $137M | · | $123M | $94M | $90M | · | $106M | |
| Current Assets | $1.81B | $1.83B | $1.98B | $1.82B | $1.68B | $1.46B | $1.54B | $1.55B | $1.48B | $1.69B | · | $1.97B | $1.87B | $1.94B | · | $1.73B | |
| PP&E (Net) | $1.69B | $1.70B | $1.73B | $1.74B | $1.72B | $1.63B | $1.58B | $1.57B | $1.49B | $1.45B | · | $1.31B | $1.26B | $1.22B | · | $1.07B | |
| PP&E (Gross) | $3.25B | $3.22B | $3.22B | $3.23B | $3.18B | $3.01B | $2.99B | $2.99B | $2.86B | $2.79B | · | $2.61B | $2.54B | $2.48B | · | $2.23B | |
| Accum. Depreciation | $1.56B | $1.52B | $1.50B | $1.49B | $1.46B | $1.37B | $1.40B | $1.42B | $1.37B | $1.34B | · | $1.30B | $1.28B | $1.26B | · | $1.16B | |
| Goodwill | $109M | $109M | $110M | $111M | $111M | $108M | $106M | $109M | $107M | $108M | $108M | $107M | $108M | $108M | $107M | $104M | |
| Intangibles | $6M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $13M | $14M | · | $16M | $17M | $18M | · | $18M | |
| Other Non-current Assets | $83M | $81M | $80M | $76M | $70M | $70M | $74M | $69M | $50M | $19M | · | $39M | $40M | $37M | · | $53M | |
| Total Assets | $4.08B | $4.11B | $4.27B | $4.11B | $3.95B | $3.62B | $3.64B | $3.68B | $3.49B | $3.60B | · | $3.75B | $3.67B | $3.72B | · | $3.32B | |
| Accounts Payable | $253M | $252M | $254M | $256M | $239M | $228M | $239M | $224M | $212M | $240M | · | $220M | $218M | $234M | · | $189M | |
| Accrued Liabilities | $34M | $47M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $640M | $674M | $655M | $635M | $605M | $527M | $550M | $516M | $634M | $648M | · | $534M | $512M | $535M | · | $457M | |
| Capital Leases | $88M | $92M | $96M | $74M | $80M | $79M | $82M | $82M | $85M | $82M | · | $83M | $87M | $90M | · | $77M | |
| Deferred Tax | $22M | $23M | $23M | $23M | $23M | $21M | $20M | $9M | $14M | $13M | · | $16M | $15M | $14M | · | $17M | |
| Other Non-current Liabilities | $90M | $88M | $75M | $75M | $70M | $66M | $62M | $67M | $63M | $58M | · | $55M | $55M | $56M | · | $34M | |
| Total Liabilities | $1.09B | $1.12B | $1.09B | $1.05B | $1.02B | $935M | $961M | $923M | $913M | $922M | · | $886M | $923M | $947M | · | $846M | |
| Long-term Debt | $203M | $203M | $203M | $203M | $203M | $203M | $203M | $203M | $206M | $206M | · | $207M | $208M | $208M | · | $209M | |
| Total Debt | $203M | $203M | · | $203M | $203M | $203M | · | $203M | $206M | $206M | · | $207M | $208M | $208M | · | $209M | |
| Common Stock | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | · | $19M | $19M | $19M | · | $19M | |
| Paid-in Capital | $0 | $0 | $0 | $0 | $0 | $2M | $22M | $23M | $34M | $55M | · | $123M | $158M | $181M | · | $231M | |
| Retained Earnings | $4.62B | $4.48B | $4.37B | $4.26B | $4.14B | $4.03B | $3.96B | $3.86B | $3.72B | $3.62B | · | $3.42B | $3.25B | $3.11B | · | $2.91B | |
| Treasury Stock | $1.51B | $1.38B | $1.11B | $1.13B | $1.14B | $1.16B | $1.06B | $1.01B | $980M | $825M | · | $466M | $501M | $369M | · | $383M | |
| AOCI | $-140M | $-125M | $-106M | $-102M | $-89M | $-206M | $-258M | $-136M | $-217M | $-192M | · | $-223M | $-184M | $-168M | · | $-308M | |
| Stockholders' Equity | $2.99B | $2.99B | $3.18B | $3.05B | $2.93B | $2.68B | $2.68B | $2.75B | $2.58B | $2.68B | $2.88B | $2.87B | $2.75B | $2.78B | $2.68B | $2.47B | |
| Liabilities + Equity | $4.08B | $4.11B | $4.27B | $4.11B | $3.95B | $3.62B | $3.64B | $3.68B | $3.49B | $3.60B | · | $3.75B | $3.67B | $3.72B | · | $3.32B | |
| Shares Outstanding | 70,400,000 | 70,900,000 | 72,000,000 | 71,900,000 | 71,900,000 | 71,800,000 | 72,300,000 | 72,500,000 | 72,600,000 | 73,000,000 | · | 74,000,000 | 73,900,000 | 74,200,000 | · | 74,000,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $46M | $45M | $47M | $43M | $41M | $40M | $41M | $40M | $39M | $36M | · | · | · | · | · | · | |
| Stock-based Comp | $11M | $7M | $7M | $8M | $7M | $1M | $4M | $5M | $4M | $5M | $1M | $6M | $8M | $8M | $7M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-23M | $-8M | |
| Restructuring | · | · | · | $900.0K | $800.0K | $800.0K | · | $-2M | $0 | $0 | · | $0 | · | · | · | · | |
| Other Non-cash | · | $-204M | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $124M | $90M | $251M | $197M | $177M | $129M | $190M | $180M | $165M | $118M | $239M | $230M | $169M | $138M | $231M | $169M | |
| CapEx | $43M | $43M | $76M | $63M | $75M | $71M | $105M | $81M | $100M | $91M | $109M | $96M | $75M | $82M | $95M | $58M | |
| Investing Cash Flow | $-43M | $-43M | $-76M | $-63M | $-75M | $-71M | $-105M | $-82M | $-101M | $-91M | $-109M | $-96M | $-82M | $-82M | $-95M | $-59M | |
| Debt Issued | · | · | · | · | · | · | · | $130M | · | · | · | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $157M | $298M | $0 | $0 | $500.0K | $134M | $54M | $52M | $187M | $267M | $177M | $28M | $173M | $60M | $-100.0K | $27M | |
| Net Stock Activity | · | $-298M | · | · | · | $-134M | · | · | · | $-267M | · | · | · | $-60M | · | · | |
| Dividends Paid | $16M | $16M | $16M | $15M | $15M | $15M | $15M | $14M | $15M | $15M | $15M | $14M | $14M | $14M | $14M | $14M | |
| Financing Cash Flow | $-165M | $-309M | $-12M | $-12M | $-15M | $-147M | $-69M | $-64M | $-218M | $-271M | $-190M | $-22M | $-177M | $-71M | $-10M | $-75M | |
| Net Change in Cash | $-86M | $-270M | $163M | $119M | $106M | $-80M | $-6M | $45M | $-156M | $-252M | $-45M | $102M | $-90M | $-8M | $165M | $10M | |
| Free Cash Flow | · | $47M | · | · | · | $58M | · | · | · | $28M | · | · | · | $56M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $26M | · | · | · | $54M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 37.7% | 35.1% | · | 36.6% | 35.7% | 33.2% | · | 35.4% | 32.8% | 33.1% | · | 38.6% | 38.7% | 37.9% | · | 39.0% | |
| Operating Margin | 20.5% | 21.0% | · | 20.8% | 20.1% | 15.3% | · | 21.6% | 18.0% | 17.7% | · | 23.7% | 24.2% | 21.7% | · | 27.1% | |
| Net Margin | 17.6% | 16.4% | · | 17.4% | 17.2% | 12.9% | · | 18.2% | 15.8% | 16.6% | · | 21.6% | 20.6% | 19.5% | · | 17.6% | |
| Pretax Margin | 20.6% | 21.3% | · | 21.4% | 20.5% | 15.8% | · | 22.0% | 18.3% | 18.3% | · | 25.0% | 24.5% | 22.0% | · | 19.8% | |
| EBITDA Margin | 25.8% | 26.3% | · | 26.2% | 25.4% | 21.1% | · | 21.6% | 18.0% | 17.7% | · | 23.7% | 24.2% | 21.7% | · | 27.1% | |
| ROA | 3.8% | 3.6% | · | 3.6% | 3.5% | 2.5% | · | 3.7% | 3.1% | 3.1% | · | 4.6% | 4.4% | 4.0% | · | 3.7% | |
| ROE | 5.2% | 4.9% | · | 4.8% | 4.8% | 3.4% | · | 4.8% | 4.2% | 4.2% | · | 6.0% | 6.0% | 5.5% | · | 5.2% | |
| ROIC | 4.6% | 4.2% | · | 4.1% | 4.0% | 2.9% | · | 4.4% | 3.8% | 3.7% | · | 4.9% | 5.0% | 4.4% | · | 5.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.7 | · | 2.9 | 2.8 | 2.8 | · | 3.0 | 2.3 | 2.6 | · | 3.7 | 3.7 | 3.6 | · | 3.8 | |
| Quick Ratio | 1.8 | 1.8 | · | 2.0 | 1.8 | 1.8 | · | 2.0 | 1.5 | 1.7 | · | 2.7 | 2.6 | 2.6 | · | 2.7 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | 230.4 | · | 76.8 | · | 61.1 | 67.6 | 70.6 | · | 84.6 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.1 | · | 1.2 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.1 | |
| Receivables Turnover | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.4 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $42.47 | $42.18 | · | $42.44 | $40.74 | $37.37 | · | $37.96 | $35.49 | $36.72 | · | $38.76 | $37.17 | $37.42 | · | $33.39 | |
| Revenue / Share | $12.23 | $11.67 | · | $11.08 | $10.57 | $9.56 | · | $10.18 | $9.53 | $9.36 | · | $9.93 | $10.00 | $9.47 | · | $9.07 | |
| Cash Flow / Share | · | $1.24 | · | · | · | $1.77 | · | · | · | $1.59 | · | · | · | $1.82 | · | · | |
| Cash / Share | $6.19 | $7.35 | · | $8.74 | $7.09 | $5.63 | · | $6.77 | $6.15 | $8.24 | · | $12.14 | $10.78 | $11.94 | · | $9.85 | |
| Dividend / Share | · | $0.22 | $0.22 | $0.22 | $0.21 | $0.21 | · | · | $0.20 | $0.20 | · | · | $0.19 | $0.19 | · | · | |
| EPS (TTM) | $7.81 | $7.48 | · | $6.75 | $6.68 | $6.37 | · | $6.74 | $7.03 | $7.58 | · | $7.42 | $6.87 | $7.29 | · | $8.26 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.33B | $3.22B | · | $3.02B | $2.96B | $2.90B | · | $2.88B | $2.88B | $2.93B | · | $2.93B | $2.87B | $2.88B | · | $2.91B | |
| Net Income TTM | $565M | $543M | · | $492M | $488M | $467M | · | $500M | $525M | $569M | · | $559M | $519M | $552M | · | $631M | |
| Market Cap | $25.27B | $17.77B | · | $18.86B | $15.73B | $16.07B | · | $21.76B | $23.91B | $28.89B | · | $27.77B | $28.26B | $25.71B | · | $18.21B | |
| Enterprise Value | $25.04B | $17.45B | · | $18.44B | $15.42B | $15.87B | · | $21.47B | $23.67B | $28.49B | · | $27.07B | $27.68B | $25.03B | · | $17.69B | |
| P/E | 46.0 | 33.5 | · | 38.9 | 32.8 | 35.1 | · | 44.5 | 46.9 | 52.2 | · | 50.6 | 55.7 | 47.5 | · | 29.8 | |
| P/S | 7.6 | 5.5 | · | 6.2 | 5.3 | 5.6 | · | 7.6 | 8.3 | 9.9 | · | 9.5 | 9.9 | 8.9 | · | 6.3 | |
| P/B | 8.5 | 5.9 | · | 6.2 | 5.4 | 6.0 | · | 7.9 | 9.3 | 10.8 | · | 9.7 | 10.3 | 9.3 | · | 7.4 | |
| P / Tangible Book | 8.8 | 6.2 | · | 6.4 | 5.6 | 6.3 | · | 8.3 | 9.7 | 11.3 | · | 10.1 | 10.8 | 9.7 | · | 7.8 | |
| P / Cash Flow | · | 197.7 | · | · | · | 124.2 | · | · | · | 244.4 | · | · | · | 186.2 | · | · | |
| EV / Revenue | 7.5 | 5.4 | · | 6.1 | 5.2 | 5.5 | · | 7.5 | 8.2 | 9.7 | · | 9.3 | 9.7 | 8.7 | · | 6.1 | |
| Dividend Yield | 0.25% | 0.35% | · | 0.32% | 0.38% | 0.37% | · | 0.27% | 0.24% | 0.20% | · | 0.20% | 0.20% | 0.21% | · | 0.29% | |
| Earnings Yield | 2.2% | 3.0% | · | 2.6% | 3.0% | 2.9% | · | 2.2% | 2.1% | 1.9% | · | 2.0% | 1.8% | 2.1% | · | 3.4% | |
| Payout Ratio | · | 11.4% | · | · | · | 16.9% | · | · | · | 12.8% | · | · | · | 10.1% | · | · | |
| Annual Payout | $62M | $62M | · | $61M | $60M | $60M | · | $59M | $58M | $58M | · | $56M | $56M | $55M | · | $53M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $3.07B | $2.89B | $2.95B | $2.89B | $2.83B |
| Marża Brutto % | 35.9% | 34.5% | 38.3% | 39.4% | 41.5% |
| Marża Operacyjna % | 19.0% | 19.7% | 22.9% | 25.4% | 26.6% |
| Zysk netto | $494M | $493M | $593M | $586M | $662M |
| Rozwodniony EPS | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Wskaźnik bieżący | 3.0 | 2.8 | 2.9 | 3.7 | 2.9 |
| Wskaźnik Szybkości | 2.1 | 1.9 | 2.0 | 2.7 | 2.1 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $469M | $276M | $414M | $439M | $331M |
Właściciele instytucjonalni (13F) 901 emitentów · $26.8B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
901
Wartość posiadanych akcji
$26.8B
Nowe pozycje
151
Zamknięte pozycje
61
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 151 (+50 vs poprzedni kw.) | 61 (-59 vs poprzedni kw.) | 302 (+42 vs poprzedni kw.) | 261 (-16 vs poprzedni kw.) | -806K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2 624 608 060 | 9 539 173 | 9,78% | Akcje |
| BlackRock, Inc. | $2 387 990 373 | 6 651 784 | 8,90% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 656 115 106 | 4 613 134 | 6,17% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 441 659 994 | 4 015 766 | 5,37% | Akcje |
| FMR LLC | $1 283 358 871 | 3 574 816 | 4,78% | Akcje |
| STATE STREET CORP | $1 202 182 582 | 3 348 698 | 4,48% | Akcje |
| Artisan Partners Limited Partnership | $865 833 483 | 2 411 792 | 3,23% | Akcje |
| Bank of New York Mellon Corp | $733 732 610 | 2 043 823 | 2,73% | Akcje |
| GENERATION INVESTMENT MANAGEMENT LLP | $728 167 598 | 2 028 322 | 2,71% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $680 551 590 | 1 903 279 | 2,54% | Akcje |
| MORGAN STANLEY | $568 135 105 | 1 582 546 | 2,12% | Akcje |
| JPMORGAN CHASE & CO | $413 034 644 | 1 164 527 | 1,54% | Akcje |
| BROWN ADVISORY INC | $386 042 699 | 1 075 309 | 1,44% | Akcje |
| Longview Partners (Guernsey) LTD | $371 143 534 | 1 033 826 | 1,38% | Akcje |
| Invesco Ltd. | $362 536 872 | 1 009 852 | 1,35% | Akcje |
| NORGES BANK | $309 786 485 | 862 915 | 1,15% | Akcje |
| GOLDMAN SACHS GROUP INC | $292 503 231 | 814 772 | 1,09% | Akcje |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $273 063 362 | 760 622 | 1,02% | Akcje |
| TD Asset Management Inc | $262 448 386 | 731 054 | 0,98% | Akcje |
| NORTHERN TRUST CORP | $254 682 139 | 709 421 | 0,95% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $226 268 769 | 902 764 | 0,84% | Akcje |
| Capital Research Global Investors | $218 710 339 | 609 221 | 0,81% | Akcje |
| VAN ECK ASSOCIATES CORP | $217 106 686 | 604 754 | 0,81% | Akcje |
| ProShare Advisors LLC | $214 690 616 | 598 024 | 0,80% | Akcje |
| Findlay Park Partners LLP | $214 195 914 | 596 646 | 0,80% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $209 650 256 | 583 984 | 0,78% | Akcje |
| Epoch Investment Partners, Inc. | $201 957 963 | 562 557 | 0,75% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $187 274 798 | 521 707 | 0,70% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $182 295 174 | 507 786 | 0,68% | Akcje |
| SEI INVESTMENTS CO | $178 687 081 | 497 734 | 0,67% | Akcje |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $177 824 906 | 495 334 | 0,66% | Akcje |
| Legal & General Group Plc | $176 137 604 | 490 634 | 0,66% | Akcje |
| APG Asset Management N.V. | $176 024 611 | 560 582 | 0,66% | Akcje |
| Nuveen, LLC | $160 169 658 | 446 156 | 0,60% | Akcje |
| GATES FOUNDATION TRUST | $159 575 500 | 444 500 | 0,59% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $157 499 762 | 438 718 | 0,59% | Akcje |
| ROYAL BANK OF CANADA | $155 897 000 | 434 255 | 0,58% | Akcje |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $149 813 786 | 417 309 | 0,56% | Akcje |
| DEUTSCHE BANK AG\ | $147 440 941 | 410 699 | 0,55% | Akcje |
| Liontrust Investment Partners LLP | $144 401 647 | 402 233 | 0,54% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $142 380 118 | 396 602 | 0,53% | Akcje |
| Amundi | $138 326 651 | 385 311 | 0,52% | Akcje |
| UBS Group AG | $134 395 599 | 374 361 | 0,50% | Akcje |
| CITADEL ADVISORS LLC | $126 644 071 | 352 769 | 0,47% | Akcje |
| BANK OF AMERICA CORP /DE/ | $125 823 095 | 350 482 | 0,47% | Akcje |
| Stonehage Fleming Financial Services Holdings Ltd | $122 154 417 | 340 263 | 0,46% | Akcje |
| Quantinno Capital Management LP | $110 613 883 | 308 116 | 0,41% | Akcje |
| Point72 Asset Management, L.P. | $101 739 164 | 283 396 | 0,38% | Akcje |
| Holocene Advisors, LP | $98 876 139 | 275 421 | 0,37% | Akcje |
| Russell Investments Group, Ltd. | $97 547 721 | 271 862 | 0,36% | Akcje |
Insiderzy spółki 64 insiderów · 39 dyrektorzy generalni · 26 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michel Lagarde | President and CEO | 8 września 2026 A | · | 0 | 0 | $0 |
| Eric Mark Green | President, CEO and Board Chair | 1 marca 2026 A | 175 161 | 0 | 0 | $0 |
| Donald E Morel JR | Chair of the Board & CEO | 30 czerwca 2015 A | 774 187 | 0 | 0 | $0 |
| Bernard Birkett | Sr VP, Chief Financial Officer | 18 lutego 2025 A | 7 520 | 0 | 0 | $0 |
| William J Federici | Sr. VP & CFO | 8 czerwca 2018 M | 227 812 | 0 | 0 | $0 |
| Warwick Bedwell | President, Pharma Pkgs Systems | 24 lutego 2016 M | 38 778 | 0 | 0 | $0 |
| Christopher G Ryan | President, PPS, Americas | 23 lutego 2016 A | 684 | 0 | 0 | $0 |
| Heino Lennartz | President Europe | 23 lutego 2016 A | 30 707 | 0 | 0 | $0 |
| John E Paproski | President-Delivery Systems | 23 lutego 2016 A | 78 223 | 0 | 0 | $0 |
| Donald A Mcmillan | President Pharma Systems NA | 21 lutego 2012 A | 15 007 | 0 | 0 | $0 |
| Steven A Ellers | COO & President | 22 lutego 2011 A | 156 544 | 0 | 0 | $0 |
| Ronald Van Dijk | President Asia Pacific | 4 maja 2010 M | 7 527 | 0 | 0 | $0 |
| Robert S Hargesheimer | President-The Tech Group | 6 marca 2009 F | 17 587 | 0 | 0 | $0 |
| Bruce S Morra | Div President - Drug Delivery | 31 grudnia 2004 A | 3 074 | 0 | 0 | $0 |
| Matthew T Mullarkey | Chief Operating Officer | 11 grudnia 2009 A | 152 | 0 | 0 | $0 |
| Annette F Favorite | Sr. VP & Chief HR Officer | 15 września 2026 M | 21 818 | 0 | 7 | $-6 303 498 |
| Shane Alden Campbell | SVP, Proprietary Segment | 12 maja 2026 M | 613 | 0 | 0 | $0 |
| Chad Winters | VP, Chief Accounting Officer | 27 kwietnia 2026 M | 1 523 | 0 | 1 | $-269 400 |
| Rodolphe Jean Poussot | SVP, Strategy & Corporate Dev | 1 marca 2026 A | 561 | 0 | 0 | $0 |
| Norman D. Finch Jr. | SVP, GC & Corporate Secretary | 1 marca 2026 A | · | 0 | 0 | $0 |
| Charles Witherspoon | VP & Treasurer | 20 lutego 2026 M | 1 408 | 0 | 0 | $0 |
| Cindy Reiss-Clark | Chief Commercial Officer | 18 lutego 2025 A | 5 047 | 0 | 0 | $0 |
| Kimberly Banks Mackay | SVP, GC & Corporate Secretary | 18 lutego 2025 A | 1 512 | 0 | 0 | $0 |
| Silji Abraham | SVP, Chief Technology Officer | 29 października 2024 M | 3 138 | 0 | 0 | $0 |
| Quintin J Lai | VP Strat & Investor Relations | 20 lutego 2024 A | 4 359 | 0 | 0 | $0 |
| David A Montecalvo | SVP, Glob Ops and Supply Chain | 22 lutego 2022 A | 13 731 | 0 | 0 | $0 |
| George Lloyd Miller | Sr. VP, GC & Corp. Sec. | 6 listopada 2020 M | 7 540 | 0 | 0 | $0 |
| Daniel Malone | Vice President & Controller | 30 kwietnia 2019 M | 29 020 | 0 | 0 | $0 |
| Karen Flynn | Sr VP & Chief Commercial Offic | 19 lutego 2019 A | 23 692 | 0 | 0 | $0 |
| Michael A Anderson | Vice President & Treasurer | 1 marca 2016 M | 55 507 | 0 | 0 | $0 |
| Richard D Luzzi | Sr. VP, Human Resources | 27 lutego 2015 M | 90 724 | 0 | 0 | $0 |
| John R Gailey | Sr. VP, Gen. Counsel & Sec. | 17 lutego 2015 A | 62 881 | 0 | 0 | $0 |
| Rachael M Bushey | VP, Deputy Gen Coun & Corp Sec | 24 lutego 2014 A | 1 019 | 0 | 0 | $0 |
| Jeffrey C Hunt | VP Pharma Pckg Systems | 24 lutego 2014 A | 25 953 | 0 | 0 | $0 |
| Joseph E Abbott | Corporate Controller | 25 lutego 2011 F | 18 341 | 0 | 0 | $0 |
| Fabio De Sampaio Doria Filho | Pres., Europe & Asia Pacific | 24 lutego 2009 A | · | 0 | 0 | $0 |
| Robert J Keating | Pres. Europe & Asia Pacific | 24 lutego 2009 A | 28 037 | 0 | 0 | $0 |
| Linda R Altemus | VP & Chief Compliance Officer | 27 stycznia 2006 A | 4 547 | 0 | 0 | $0 |
| Herbert L Hugill | Pres.of the Americas, Pharma. | 7 października 2005 A | 6 504 | 0 | 0 | $0 |
| Janet Brutschea Haugen | Dyrektor | 30 września 2026 A | 2 373 | 0 | 0 | $0 |
| Stephen H Lockhart | Dyrektor | 4 maja 2026 A | 3 523 | 0 | 0 | $0 |
| Molly Joseph | Dyrektor | 4 maja 2026 A | 4 398 | 0 | 0 | $0 |
| William F Feehery | Dyrektor | 4 maja 2026 A | 32 519 | 0 | 0 | $0 |
| Paolo Pucci | Dyrektor | 4 maja 2026 A | 11 854 | 0 | 0 | $0 |
| Deborah L Keller | Dyrektor | 4 maja 2026 A | 11 560 | 0 | 0 | $0 |
| Douglas A Michels | Dyrektor | 4 maja 2026 A | 46 496 | 0 | 0 | $0 |
| Robert F Friel | Dyrektor | 4 maja 2026 A | 5 513 | 0 | 0 | $0 |
| Mark A Buthman | Dyrektor | 4 maja 2026 A | 44 309 | 0 | 0 | $0 |
| Goldman Myla Lai | Dyrektor | 4 maja 2026 A | 20 435 | 0 | 0 | $0 |
| Thomas W Hofmann | Dyrektor | 6 maja 2025 A | 44 637 | 0 | 0 | $0 |
| ZENNER PATRICK J | Dyrektor | 31 marca 2022 A | 67 509 | 0 | 0 | $0 |
| Paula A Johnson | Dyrektor | 5 maja 2020 A | 48 754 | 0 | 0 | $0 |
| John H Weiland | Dyrektor | 29 grudnia 2017 A | 45 359 | 0 | 0 | $0 |
| Anthony Welters | Dyrektor | 31 marca 2016 A | 43 536 | 0 | 0 | $0 |
| Robert L Johnson | Dyrektor | 22 sierpnia 2013 S | 19 437 | 0 | 0 | $0 |
| Robert C Young | Dyrektor | 30 września 2011 A | 19 705 | 0 | 0 | $0 |
| Geoffrey F Worden | Dyrektor | 3 maja 2011 A | 19 082 | 0 | 0 | $0 |
| John P Neafsey | Dyrektor | 3 maja 2011 A | 42 594 | 0 | 0 | $0 |
| Jenne K Britell | Dyrektor | 6 maja 2008 A | 6 921 | 0 | 0 | $0 |
| LONGFIELD WILLIAM H | Dyrektor | 29 grudnia 2006 J | · | 0 | 0 | $0 |
| Tenley E Albright | Dyrektor | 2 maja 2006 A | 3 576 | 0 | 0 | $0 |
| George W Ebright | Dyrektor | 28 czerwca 2005 A | · | 0 | 0 | $0 |
| John W Conway | Dyrektor | 5 maja 2004 A | · | 0 | 0 | $0 |
| Robert W. Mcmahon | · | 11 sierpnia 2026 M | 7 021 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 123 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 4,91% | 6 561 NS | 31 lipca 2026 | N-PORT |
| SMCO · Tidal Trust II | 2,39% | 9 959 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,78% | 43 708 SH | 23 października 2026 | Dziennie |
| NUMG · Nushares ETF Trust | 1,73% | 17 777 NS | 31 lipca 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,65% | 170 776 NS | 31 lipca 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 0,92% | 11 995 NS | 31 lipca 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,80% | 5 698 NS | 31 lipca 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,76% | 340 NS | 31 lipca 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,74% | 28 638 NS | 31 lipca 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0,56% | 541 243 SH | 19 sierpnia 2026 | Dziennie |
| VLLU · Harbor ETF Trust | 0,51% | 69 NS | 31 lipca 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,47% | 2 866 NS | 31 lipca 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,46% | 29 735 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,40% | 12 340 NS | 31 lipca 2026 | N-PORT |
| IYH · iShares Trust | 0,39% | 40 908 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,38% | 216 521 SH | 19 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,37% | 6 225 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,36% | 34 263 NS | 31 lipca 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,34% | 15 700 NS | 31 lipca 2026 | N-PORT |
| IMCG · iShares Trust | 0,34% | 39 110 SH | 11 września 2026 | Dziennie |
| IXJ · iShares Trust | 0,31% | 37 058 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,28% | 1 390 NS | 31 lipca 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,24% | 1 530 972 SH | 19 sierpnia 2026 | Dziennie |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 3 254 NS | 31 lipca 2026 | N-PORT |
| IWS · iShares Trust | 0,24% | 104 246 SH | 11 września 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,23% | 582 603 SH | 23 października 2026 | Dziennie |
| SDVD · First Trust Exchange-Traded Fund IV | 0,22% | 5 847 NS | 31 lipca 2026 | N-PORT |
| SIZE · iShares Trust | 0,22% | 2 713 SH | 11 września 2026 | Dziennie |
| SUSA · iShares Trust | 0,21% | 24 221 SH | 11 września 2026 | Dziennie |
| EUSA · iShares, Inc. | 0,20% | 11 061 SH | 11 września 2026 | Dziennie |
| PEXL · Pacer Funds Trust | 0,20% | 291 NS | 31 lipca 2026 | N-PORT |
| IWR · iShares Trust | 0,18% | 286 112 SH | 11 września 2026 | Dziennie |
| DEUS · DBX ETF Trust | 0,17% | 1 536 NS | 31 sierpnia 2026 | N-PORT |
| IMCB · iShares Trust | 0,17% | 8 258 SH | 11 września 2026 | Dziennie |
| EGUS · iShares Trust | 0,16% | 125 SH | 11 września 2026 | Dziennie |
| SNPD · DBX ETF Trust | 0,15% | 13 NS | 31 sierpnia 2026 | N-PORT |
| MTUM · iShares Trust | 0,14% | 100 332 SH | 11 września 2026 | Dziennie |
| XOEF · iShares Trust | 0,14% | 89 SH | 11 września 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,13% | 16 052 SH | 23 października 2026 | Dziennie |
| EVUS · iShares Trust | 0,13% | 1 427 SH | 11 września 2026 | Dziennie |
| CATH · Global X Funds | 0,11% | 4 370 NS | 31 lipca 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,11% | 399 120 SH | 19 sierpnia 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,11% | 2 188 SH | 22 października 2026 | Dziennie |
| ESGU · iShares Trust | 0,10% | 51 366 SH | 11 września 2026 | Dziennie |
| USXF · iShares Trust | 0,10% | 4 199 SH | 11 września 2026 | Dziennie |
| PFM · Invesco Exchange-Traded Fund Trust | 0,10% | 2 006 SH | 23 października 2026 | Dziennie |
| NULC · Nushares ETF Trust | 0,10% | 198 NS | 31 lipca 2026 | N-PORT |
| VUG · VANGUARD INDEX FUNDS | 0,09% | 939 597 SH | 19 sierpnia 2026 | Dziennie |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,09% | 16 234 SH | 19 sierpnia 2026 | Dziennie |
| IVE · iShares Trust | 0,08% | 117 239 SH | 11 września 2026 | Dziennie |
| MNZL · EA Series Trust | 0,08% | 54 NS | 31 lipca 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,08% | 744 NS | 31 lipca 2026 | N-PORT |
| IUSV · iShares Trust | 0,08% | 61 700 SH | 11 września 2026 | Dziennie |
| QUAL · iShares Trust | 0,08% | 103 026 SH | 11 września 2026 | Dziennie |
| ILCG · iShares Trust | 0,08% | 6 825 SH | 11 września 2026 | Dziennie |
| QARP · DBX ETF Trust | 0,08% | 172 NS | 31 sierpnia 2026 | N-PORT |
| CHRI · Global X Funds | 0,07% | 17 NS | 31 lipca 2026 | N-PORT |
| SUSL · iShares Trust | 0,07% | 2 523 SH | 11 września 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,07% | 42 216 SH | 19 sierpnia 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,07% | 31 528 NS | 31 lipca 2026 | N-PORT |
| DSI · iShares Trust | 0,07% | 10 798 SH | 11 września 2026 | Dziennie |
| USSG · DBX ETF Trust | 0,07% | 1 186 NS | 31 sierpnia 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,07% | 6 413 NS | 31 lipca 2026 | N-PORT |
| IWD · iShares Trust | 0,06% | 155 152 SH | 11 września 2026 | Dziennie |
| HLAL · Listed Funds Trust | 0,06% | 1 784 NS | 31 sierpnia 2026 | N-PORT |
| LGDX · Tidal Trust III | 0,06% | 261 NS | 31 lipca 2026 | N-PORT |
| AQLT · iShares Trust | 0,06% | 588 SH | 11 września 2026 | Dziennie |
| MPLY · Strategy Shares | 0,06% | 28 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,06% | 951 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,06% | 77 904 NS | 31 lipca 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,05% | 2 208 SH | 23 października 2026 | Dziennie |
| TOPC · iShares Trust | 0,05% | 43 SH | 11 września 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,04% | 2 923 NS | 31 lipca 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,04% | 11 342 SH | 23 października 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,04% | 422 SH | 23 października 2026 | Dziennie |
| XVV · iShares Trust | 0,04% | 818 SH | 11 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,04% | 15 020 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,04% | 1 834 804 SH | 19 sierpnia 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,04% | 82 509 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,04% | 11 528 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,04% | 15 807 SH | 19 sierpnia 2026 | Dziennie |
| XYLD · Global X Funds | 0,04% | 3 763 NS | 31 lipca 2026 | N-PORT |
| XRMI · Global X Funds | 0,04% | 58 NS | 31 lipca 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,04% | 6 229 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,04% | 73 NS | 31 lipca 2026 | N-PORT |
| XCLR · Global X Funds | 0,04% | 4 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,04% | 3 645 NS | 31 lipca 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,04% | 7 491 NS | 31 lipca 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 9 724 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,04% | 890 519 SH | 11 września 2026 | Dziennie |
| VOTE · TCW ETF Trust | 0,04% | 1 195 NS | 31 lipca 2026 | N-PORT |
| ILCB · iShares Trust | 0,04% | 1 389 SH | 11 września 2026 | Dziennie |
| DFVX · Dimensional ETF Trust | 0,04% | 571 NS | 31 lipca 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 56 SH | 23 października 2026 | Dziennie |
| XTR · Global X Funds | 0,04% | 5 NS | 31 lipca 2026 | N-PORT |
| CRBN · iShares Trust | 0,04% | 1 197 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,03% | 3 050 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,03% | 21 330 NS | 31 lipca 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,03% | 267 NS | 31 lipca 2026 | N-PORT |
| USCL · iShares Trust | 0,03% | 2 814 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,03% | 48 245 SH | 11 września 2026 | Dziennie |
| QDPL · Pacer Funds Trust | 0,03% | 1 690 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,03% | 91 739 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,03% | 19 220 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 8 022 SH | 22 października 2026 | Dziennie |
| ESG · FlexShares Trust | 0,03% | 120 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,03% | 2 243 244 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,03% | 5 888 SH | 19 sierpnia 2026 | Dziennie |
| TOV · EA Series Trust | 0,03% | 250 NS | 31 lipca 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,03% | 490 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,03% | 201 SH | 11 września 2026 | Dziennie |
| KOKU · DBX ETF Trust | 0,03% | 669 NS | 31 sierpnia 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,03% | 5 522 NS | 31 lipca 2026 | N-PORT |
| URTH · iShares, Inc. | 0,03% | 6 563 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,03% | 1 706 NS | 31 lipca 2026 | N-PORT |
| ACWI · iShares Trust | 0,02% | 23 006 SH | 11 września 2026 | Dziennie |
| APUE · Trust for Professional Managers | 0,02% | 1 585 NS | 31 sierpnia 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 59 592 SH | 19 sierpnia 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 5 134 SH | 23 października 2026 | Dziennie |
| VOXP · Advisors Series Trust | 0,02% | 3 NS | 31 lipca 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,01% | 3 NS | 31 sierpnia 2026 | N-PORT |
| DGRO · iShares Trust | 0,01% | 18 046 SH | 11 września 2026 | Dziennie |
| NULG · Nushares ETF Trust | 0,01% | 1 116 NS | 31 lipca 2026 | N-PORT |
WST Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 22 analityków
KUP
Średni cel
$410.00
+4,6%
7 31,8%
Mocne kupno
14 63,6%
Kup
1 4,5%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
16 analityków · 2026-10-19Średnia cel $412.88 +5,3%
Teraz
Aktualna cena $392.15
Niski$340.00
Średnia$412.88
Wysoki$459.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | · |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | · |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | · |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Lip 23, 2026